Chemical and Biomedical Engineering

Miniaturized 3D bioprinting on a 384PillarPlateÒ for assessing metabolism-induced compound toxicity.

The TeCK Fund held its second Selection Committee meeting on January 22nd, 2018 and selected two full proposals for funding. At Cleveland State University, Dr. Moo-Yeal Lee, an assistant professor, received funding to help commercialize his technology Miniaturized 3D Bioprinting of Human Cells on a Chip for Disease Modeling. The technology, developed with support from an NIH grant, is expected to provide more accurate selection of compounds in the drug discovery process prior to human trials. Dr. Lee was awarded $100,000 toward his project. The major goal of this project is to validate and commercialize a 384-pillar plate platform for metabolism-induced toxicity assays. The grant will run from February 15, 2018 to February 14, 2019.